<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04401462</url>
  </required_header>
  <id_info>
    <org_study_id>SCORE</org_study_id>
    <nct_id>NCT04401462</nct_id>
  </id_info>
  <brief_title>Scandinavian Olecranon Research in the Elderly</brief_title>
  <official_title>SCORE Trial - Scandinavian Olecranon Research in the Elderly</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oulu University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kuopio University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Satakunta Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jyväskylä Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Linkoeping</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Copenhagen University Hospital Hellerup</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Turku University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to study the difference between operative treatment, either with
      tension band wiring or plate fixation, and conservative treatment of traumatic, displaced
      olecranon fractures in elderly population in a non-inferiority study setting.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2020</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the Disabilities of Arm, Shoulder and Hand (DASH)</measure>
    <time_frame>1 year</time_frame>
    <description>Minimum value 0, maximum value 100. Higher scores mean worse outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the Disabilities of Arm, Shoulder and Hand (DASH)</measure>
    <time_frame>3 months</time_frame>
    <description>Minimum value 0, maximum value 100. Higher scores mean worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Rated Elbow Evaluation (PREE) Finnish, Swedish and Danish versions</measure>
    <time_frame>3 and 12 months</time_frame>
    <description>Minimum value 0, maximum value 100. Higher score indicates more pain and functional disability.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS (visual analogue scale) pain</measure>
    <time_frame>3 and 12 months</time_frame>
    <description>Minimum value 0, maximum value 10. Higher scores mean worse outcome ie. more pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS (visual analogue scale) satisfaction</measure>
    <time_frame>3 and 12 months</time_frame>
    <description>Minimum value 0, maximum value 10. Higher scores mean worse outcome ie. less satisfactory situation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Elbow X-rays</measure>
    <time_frame>post-operatively, 2 weeks, 3 and 12 months</time_frame>
    <description>AP and lateral view.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of elbow motion.</measure>
    <time_frame>3 and 12 months</time_frame>
    <description>The results are reported in degrees. Measurement is performed to the injured arm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of extension strength between injured and healthy elbow.</measure>
    <time_frame>12 months</time_frame>
    <description>Both arms are measured elbow flexed 60 and 90 degrees. Power is reported in grams. Measurements are performed in sitting position, back straight.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>up to 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">68</enrollment>
  <condition>Olecranon Fracture</condition>
  <arm_group>
    <arm_group_label>Operative group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>tension band wiring or plate fixation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-operative group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>conservative treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tension band wiring or plate fixation</intervention_name>
    <description>Operative fixation of olecranon fracture with either of the methods mentioned in the intervention name</description>
    <arm_group_label>Operative group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Sling or a long-arm plaster</intervention_name>
    <description>Non-operative treatment and progressive range of motion as tolerated. A long-arm plaster will be used, if necessary, for pain relief.</description>
    <arm_group_label>Non-operative group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Radiologically (standard AP and lateral radiographs) confirmed, displaced (≥2mm
             dislocation of the joint surface) fracture of the olecranon

          -  Age of patient is 75 years or over at the time of the injury

        Exclusion Criteria:

          -  A delay more than 2 weeks after traumatic event to the day of intervention

          -  Mayo type 3 fracture

          -  Fracture continuation distal to coronoideus

          -  Other acute fracture or nerve damage of the ipsilateral upper limb

          -  Old fracture (&lt;6 months) or pseudoarthrosis or unhealed nerve injury of the
             ipsilateral upper limb

          -  Open fracture

          -  Pathological fracture

          -  History of alcoholism, drug abuse, psychological or other emotional problems likely to
             jeopardize informed consent

          -  Patient's inability to understand written and spoken Finnish or Swedish or Danish

          -  Patient's denial for participation or cognitive incapability to provide consent

          -  Patient physically unfit for surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>75 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ida Rantalaiho, MD</last_name>
    <phone>+35823135040</phone>
    <email>ida.rantalaiho@tyks.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Inari Laaksonen, PhD</last_name>
    <email>inari.laaksonen@tyks.fi</email>
  </overall_contact_backup>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 19, 2020</study_first_submitted>
  <study_first_submitted_qc>May 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 26, 2020</study_first_posted>
  <last_update_submitted>May 20, 2020</last_update_submitted>
  <last_update_submitted_qc>May 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

